Differential expression of miR-873, miR-181a and miR-17-5p and their correlation with immune checkpoints PD-L1 and CD155 among hepatocellular carcinoma patients

被引：1
|
作者：
Eltahtawy, O. [1 ]
Gomaa, A. [2 ]
Youness, R. A. [3 ]
机构：
[1] German Univ Cairo, Mol Genet Res Team, Cairo, Egypt
[2] Natl Liver Inst, Hepatol Dept, Sheben Elkom, Egypt
[3] Univ Hertfordshire, Global Acad Fdn, Sch Life & Med Sci, New Cairo, Egypt
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
基金：
英国医学研究理事会;
关键词：
D O I：
10.1016/j.annonc.2021.10.046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
30P
引用
收藏
页码：S1385 / S1386
页数：2
相关论文
共 50 条
  • [21] Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma
    Sun, Guoqiang
    Miao, Ganggang
    Li, Zhitao
    Zheng, Wubin
    Zhou, Chunguang
    Sun, Guangshun
    Cao, Hongyong
    Li, Zhouxiao
    Tang, Weiwei
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [22] Heat shock protein-27 and MiR-17-5p are novel diagnostic and prognostic biomarkers for hepatocellular carcinoma in Egyptian patients
    Raafat, Nermin
    Zaher, Tarik, I
    Etewa, Rasha L.
    El-gerby, Khaled M.
    Rezk, Noha A.
    GENE REPORTS, 2020, 21
  • [23] Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
    Xiang Li
    Shaomin Wang
    Wei Mu
    Jennifer Barry
    Anna Han
    Richard L. Carpenter
    Bing-Hua Jiang
    Stephen C. Peiper
    Mỹ G. Mahoney
    Andrew E. Aplin
    Hong Ren
    Jun He
    Journal of Experimental & Clinical Cancer Research, 41
  • [24] Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
    Li, Xiang
    Wang, Shaomin
    Mu, Wei
    Barry, Jennifer
    Han, Anna
    Carpenter, Richard L.
    Jiang, Bing-Hua
    Peiper, Stephen C.
    Mahoney, My G.
    Aplin, Andrew E.
    Ren, Hong
    He, Jun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [25] Hypoxia-responsive lncRNA MIR155HG promotes PD-L1 expression in hepatocellular carcinoma cells by enhancing HIF-1α mRNA stability
    Qiu, Jiacheng
    Zhong, Fuxiu
    Zhang, Zhu
    Pan, Banglun
    Ye, Dongjie
    Zhang, Xiaoxia
    Yao, Yuxin
    Luo, Yue
    Wang, Xiaoqian
    Tang, Nanhong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 136
  • [26] lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1
    Cheng, Guohua
    Li, Yarong
    Liu, Zhaoyu
    Song, Xiang
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 30 (10): : 1043 - 1050
  • [27] HOXA-AS3 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells via the miR-455-5p/PD-L1 Axis
    Zeng, Cheng
    Ye, Shaojun
    Chen, Yu
    Zhang, Qu
    Luo, Yan
    Gai, Liang
    Luo, Bo
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [28] LINC00657 knockdown suppresses hepatocellular carcinoma progression by sponging miR-424 to regulate PD-L1 expression
    Xinling Cao
    Guanping Zhang
    Tao Li
    Chengming Zhou
    Lei Bai
    Jinming Zhao
    Turgunjan Tursun
    Genes & Genomics, 2020, 42 : 1361 - 1368
  • [29] Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes
    Vasilatou, Diamantina
    Papageorgiou, Sotirios G.
    Kontsioti, Frieda
    Kontos, Christos K.
    Tsiotra, Panayiota
    Mpakou, Vassiliki
    Pavlou, Maria-Angeliki S.
    Economopoulou, Christina
    Dimitriadis, George
    Dervenoulas, John
    Pappa, Vasiliki
    LEUKEMIA RESEARCH, 2013, 37 (03) : 251 - 258
  • [30] Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice
    Liu, Yun
    Xie, Qian
    Ma, Yao
    Lin, Chen
    Li, Jinlin
    Hu, Bing
    Liu, Chaoqi
    Zhao, Yun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 629
12345